Literature DB >> 11923845

Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization.

Sang J Ha1, Jun Chang, Man K Song, You S Suh, Hyun T Jin, Chu H Lee, Gyu H Nam, Gildon Choi, Kwan Y Choi, Sung H Lee, Won B Kim, Young C Sung.   

Abstract

Interleukin-12 (IL-12), consisting of p40 and p35 subunits, produces both p70 heterodimer and free p40. p70 is essential for the induction of T-helper 1 (Th1) and cytotoxic T-cell (CTL) immunity, whereas p40 inhibits p70-mediated function. Here, we found that mutations introduced into N-glycosylation sites (N220 of murine p40 and N222 of human p40) reduced secretion of p40 but not p70. Co-immunization of N220 mutant mIL-12 gene with hepatitis C virus (HCV) E2 DNA significantly enhanced long-term E2-specific CD8+ T-cell response and protection against tumor challenge compared with that of wild type. Our results indicate that the ratio of p70 to p40 is important for generating sustained long-term cell-mediated immunity. Thus, the mutant IL-12 could be utilized for the development of DNA vaccines as an adjuvant for the generation of long-term memory T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923845     DOI: 10.1038/nbt0402-381

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  13 in total

1.  Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models.

Authors:  Yi-Ping Li; Hye-Na Kang; Lorne-A Babiuk; Qiang Liu
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

2.  Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Authors:  E Marks; C Naudin; G Nolan; B J Goggins; G Burns; S W Mateer; J K Latimore; K Minahan; M Plank; P S Foster; R Callister; M Veysey; M M Walker; N J Talley; G Radford-Smith; S Keely
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

3.  A polymorphism in the coding region of Il12b promotes IL-12p70 and IL-23 heterodimer formation.

Authors:  Antonie Zwiers; Ivan J Fuss; Diana Seegers; Tanja Konijn; Juan J Garcia-Vallejo; Janneke N Samsom; Warren Strober; Georg Kraal; Gerd Bouma
Journal:  J Immunol       Date:  2011-02-14       Impact factor: 5.422

4.  Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.

Authors:  Jin-Won Youn; Su-Hyung Park; Jae Ho Cho; Young Chul Sung
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

Authors:  Masanori Matsui; Osamu Moriya; Maria Laura Belladonna; Sadahiro Kamiya; François A Lemonnier; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Expression of functional interleukin-12 from mouse in transgenic tomato plants.

Authors:  Abel Gutiérrez-Ortega; Claudia Sandoval-Montes; Teresa Jesús de Olivera-Flores; Leopoldo Santos-Argumedo; Miguel Angel Gómez-Lim
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 3.145

7.  The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.

Authors:  S H Seo; K S Kim; S H Park; Y S Suh; S J Kim; S-S Jeun; Y C Sung
Journal:  Gene Ther       Date:  2011-01-13       Impact factor: 5.250

Review 8.  A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12.

Authors:  David J Klinke
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

9.  Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.

Authors:  G Ahlén; F Holmström; A Gibbs; M Alheim; L Frelin
Journal:  Gene Ther       Date:  2014-05-29       Impact factor: 5.250

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.